NCT03758781
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +41 more
- Locations
-
- H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Clinical trial condition
Carcinoma, Transitional Cell
Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.
430 public trials
126 recruiting studies
Carcinoma, Transitional Cell trial results
NCT03849469
- Conditions
- Adenocarcinoma, Adnexal Diseases, Advanced or Metastatic Solid Tumors, +108 more
- Locations
-
- UCSD Medical Center - Encinitas Encinitas, California, United States
- Koman Family Outpatient Pavilion La Jolla, California, United States
- UC San Diego Medical Center - La Jolla (Jacobs Medical Center / Thornton Pavilion) La Jolla, California, United States
- UCSD Altman Clinical and Translational Research Institute Building (ACTRI) La Jolla, California, United States
NCT03785925
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
- Locations
-
- San Francisco VA Medical Center - NAVREF - PPDS San Francisco, California, United States
- Innovative Clinical Research Institute, LLC Whittier, California, United States
- Rocky Mountain Cancer Centers Aurora, Colorado, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
NCT02983045
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +55 more
- Locations
-
- UCSD, Moores Cancer Center La Jolla, California, United States
- UCLA Los Angeles, California, United States
- Stanford Cancer Institute Stanford, California, United States
- University of Colorado, Denver Denver, Colorado, United States
NCT03330886
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
- Locations
-
- Productos Roche S.A. Quimica e Industrial, División Farmacéutica Buenos Aires, Argentina
NCT03689192
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +59 more
- Locations
-
- Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Herlev, Denmark
Completed
Paclitaxel and Pembrolizumab in Treating Patients With Refractory Metastatic Urothelial Cancer
NCT02581982
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
NCT03517488
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
- Locations
-
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
- University of California San Diego Moores Cancer Center San Diego, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
NCT03464734
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Metastatic Urothelial Carcinoma, +3 more
- Locations
-
- Clinical Trial Center, Istituto Nazionale dei Tumori di Milano Milan, Italy
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
NCT03980041
- Conditions
- Advanced Cancer, Bladder Cancer, Carcinoma, +16 more
- Locations
-
- Parkview Physicians Fort Wayne, Indiana, United States
- University of MD - Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
- Karmanos Cancer Center Detroit, Michigan, United States
- Coborn Cancer Center Saint Cloud, Minnesota, United States